Cargando…
Biomarkers of early stage osteoarthritis, rheumatoid arthritis and musculoskeletal health
There is currently no biochemical test for detection of early-stage osteoarthritis (eOA). Tests for early-stage rheumatoid arthritis (eRA) such as rheumatoid factor (RF) and anti–cyclic citrullinated peptide (CCP) antibodies require refinement to improve clinical utility. We developed robust mass sp...
Autores principales: | Ahmed, Usman, Anwar, Attia, Savage, Richard S., Costa, Matthew L., Mackay, Nicola, Filer, Andrew, Raza, Karim, Watts, Richard A., Winyard, Paul G., Tarr, Joanna, Haigh, Richard C., Thornalley, Paul J., Rabbani, Naila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365413/ https://www.ncbi.nlm.nih.gov/pubmed/25788417 http://dx.doi.org/10.1038/srep09259 |
Ejemplares similares
-
Protein oxidation, nitration and glycation biomarkers for early-stage diagnosis of osteoarthritis of the knee and typing and progression of arthritic disease
por: Ahmed, Usman, et al.
Publicado: (2016) -
Frequency of Th17 CD20+ cells in the peripheral blood of rheumatoid arthritis patients is higher compared to healthy subjects
por: Eggleton, Paul, et al.
Publicado: (2011) -
Glycation marker glucosepane increases with the progression of osteoarthritis and correlates with morphological and functional changes of cartilage in vivo
por: Legrand, Catherine, et al.
Publicado: (2018) -
Protein glycation – biomarkers of metabolic dysfunction and early-stage decline in health in the era of precision medicine
por: Rabbani, Naila, et al.
Publicado: (2021) -
Emerging Glycation-Based Therapeutics—Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors
por: Rabbani, Naila, et al.
Publicado: (2022)